NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commerci... ( BEDMINSTER N.J. Oct. 8 /- NPS Pha...)

NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commercial Officer

Date:10/8/2007

BEDMINSTER, N.J., Oct. 8 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today the appointment of Brian O'Callaghan as senior vice president and chief commercial officer, effective October 15, 2007.

As a member of the NPS executive team, Mr. O'Callaghan will be responsible for managing the company's marketing and corporate and business development activities, including the commercial development of NPS's late-stage products and coordination of its joint-venture partnerships with other companies. He will report to Dr. Francois Nader, executive vice president and chief operating officer of NPS.

Mr. O'Callaghan joins NPS from Covance, a global clinical research organization, where he served as general manager of the cardiac safety and IVRS business units. Previously he was North American regional business unit head for infectious diseases and transplantation/immunology at Novartis, president of BioPartners GmbH, and held sales and marketing positions at Merck KGaA, Merck & Lipha Pharmaceuticals and Pfizer.

"Brian brings to NPS more than 15 years of experience in pharmaceutical sales, marketing, business development and general management," said Dr. Nader. "We welcome his contributions to the commercialization of our late-stage product candidates PREOS(R) and GATTEX(TM) and to the success of our earlier-stage corporate collaborations."

Mr. O'Callaghan has a master's degree in business administration from Henley College and a marketing degree from Cork Regional College/Marketing Institute of Ireland.

About NPS

NPS Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of small molecules and recombinant proteins as drug
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals

Post Your Comments:

NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commerci...( BEDMINSTER N.J. Oct. 8 /- NPS Pha...),Health